Cargando…
Development and validation of circulating protein signatures as diagnostic biomarkers for biliary tract cancer
BACKGROUND & AIMS: Biliary tract cancer (BTC) is associated with a dismal prognosis, partly because it is typically diagnosed late, highlighting the need for diagnostic biomarkers. The purpose of this project was to identify and validate multiprotein signatures that could differentiate patients...
Autores principales: | Christensen, Troels D., Maag, Emil, Larsen, Ole, Feltoft, Claus L., Nielsen, Kaspar René, Jensen, Lars Henrik, Leerhøy, Bonna, Hansen, Carsten P., Chen, Inna M., Nielsen, Dorte L., Johansen, Julia S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867981/ https://www.ncbi.nlm.nih.gov/pubmed/36699667 http://dx.doi.org/10.1016/j.jhepr.2022.100648 |
Ejemplares similares
-
Protein Signatures and Individual Circulating Proteins, including IL-6 and IL-15, Associated with Prognosis in Patients with Biliary Tract Cancer
por: Christensen, Troels D., et al.
Publicado: (2023) -
Determination of temporal reproducibility and variability of cancer biomarkers in serum and EDTA plasma samples using a proximity extension assay
por: Christensen, Troels D., et al.
Publicado: (2022) -
Prognostic value of circulating proteins in patients undergoing surgery for pancreatic cancer
por: Lindgaard, Sidsel C., et al.
Publicado: (2022) -
Systematic review: Incidence, risk factors, survival and treatment of bone metastases from colorectal cancer
por: Christensen, Troels Dreier, et al.
Publicado: (2018) -
Circulating Protein Biomarkers for Prognostic Use in Patients with Advanced Pancreatic Ductal Adenocarcinoma Undergoing Chemotherapy
por: Lindgaard, Sidsel C., et al.
Publicado: (2022)